CL vs DNTH · P/E 34, rev $20.38B vs rev $6.2M
Colgate-Palmolive Company (CL) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
CL currently screens at market cap $70.88B and trailing P/E 34.3. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the CL and DNTH stock pages for the full models.
Not investment advice.